
    
      In this study, eligible patients with type 2 diabetes will be randomized to either
      intermittent insulin therapy or continuous metformin therapy, after both arms have first
      undergone a short course of intensive insulin therapy. The hypothesis under study is whether
      intermittent insulin therapy can better preserve beta-cell function.
    
  